Efficacy, safety and compliance of integrated traditional Chinese and Western medicine in patients with depression in the community: a multi-center, randomized controlled study

Shandong Mental Health Center0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Patients in the community;
•2. Patients who met the ICD-10 diagnostic criteria for depressive disorder (F32 depressive episode or f33 recurrent depressive disorder);
•3. Patients aged 18-65, male or female;
•4. Subjects with 17 or more HAMD scores at baseline;
•5. Informed consent signed by the patient or his legal guardian;

•1. Patients with serious suicidal tendency;
•2. Patients with psychotic symptoms such as hallucination and delusion;
•3. Patients with serious or unstable heart, liver, kidney, endocrine, blood and other internal diseases;
•4. Patients with history of epilepsy;
•5. Patients with diagnosis of alcohol and drug dependence within one year;
•6. Patients with depression secondary to other mental or physical diseases;
•7. Women who are lactating, pregnant or likely to be pregnant during the trial;
•8. Patients currently using antidepressants;
•9. Patients who failed to use SSRIs antidepressants in the past;
•10. Patients without supervision or unable to take medicine according to doctor's advice;
•11. Patients with bipolar disorder.

发起方